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ABSTRACT 
 
Impact of Body Condition on Plasma Leptin and Insulin-like Growth Factor-I  
Concentrations in Stallions and Geldings. (December 2006) 
Tommy Neal Chancellor, B.S., Texas A&M University 
Chair of Advisory Committee: Dr. Martha M. Vogelsang 
 
The objective of this study was to more clearly define the relationship between 
body condition, plasma leptin and insulin-like growth factor-I (IGF-I) in stallions and 
geldings in moderate (5.0-5.5) versus fleshy (7.0-7.5) body condition.  Data analyses of 
physical measurements showed that there was a difference for BCS (P<0.001) even 
though the fat group only achieved a mean BCS of 6.3 + 0.2 as compared with a mean 
BCS of 5.3 + 0.1 for the moderate group.  Differences also existed for rump fat (P<0.05) 
and percent body fat (P<0.05) between BCS groups.  Analysis of physical measurements 
revealed that there was no sex effect as geldings and stallions within each group were not 
significantly different.  Analysis of plasma leptin concurred with previous reports as a 
difference (P<0.001) existed between the BCS groups.  Mean leptin concentrations were 
2.13 + 0.1 ng/ml for the fat group and 1.44 + 0.1 ng/ml for the moderate group.  After 
normalization of the data, changes in leptin concentrations still revealed a significant 
difference (P<0.05) between BCS groups, yet no difference in leptin concentrations 
between stallions and geldings was seen.  Dexamethasone (DEX) treatment on d 0 caused 
a subsequent 24 h rise in plasma leptin in both groups.  Analysis of plasma IGF-I 
revealed no difference in IGF-I concentrations between BCS groups.  Mean plasma IGF-I 
was 347.2 + 11.4 ng/ml for the fat group and 344.3 + 10.0 ng/ml for the moderate group.  
iv 
There was however a difference (P<0.05) between geldings and stallions.  Geldings 
exhibited an overall mean plasma IGF-I concentration of 360.6 + 9.1 ng/ml with stallions 
exhibiting a mean IGF-I concentration of 329.1 + 12.1 ng/ml.  The post DEX challenge 
rise seen with leptin was not evident when analyzing the change in plasma IGF-I 
concentrations.  In conclusion, the data presented herein have provided a more accurate 
profile of circulating concentrations of leptin and IGF-I in stallions and geldings of 
moderate and fleshy body condition. 
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CHAPTER I 
INTRODUCTION 
 In the twentieth century, research in endocrinology has expanded the 
understanding of hormones from hypotheses and educated conclusions to solid answers 
based upon experimental data.  This process continues on into the twenty-first century 
with the knowledge base growing ever larger.  With the myriad of hormones that operate 
within endocrine systems research interests are diverse and broad.  Two hormones of 
particular interest that this paper seeks to address are the adipocyte hormone leptin and 
insulin-like growth factor-I (IGF-I). 
 Leptin is a polypeptide hormone secreted mainly by white adipocytes.  Its primary 
function is to relay the body’s nutritional status to the brain and to regulate energy 
homeostasis and body weight.  Circulating concentrations of leptin have been shown to 
be sensitive to changes in energy intake as well as being positively correlated to the 
body’s degree of fatness.  Insulin-like growth factor-I on the other hand is a growth 
promoting polypeptide that primarily mediates the effects of growth hormone (GH) on 
the skeletal system.  Like leptin, IGF-I can exhibit changes in circulating concentrations 
with changes in body fat.  Insulin-like growth factor-I  has also been found to decrease 
along with decreases in feed intake and body condition.  Besides changes in nutritional 
intake, other factors can influence the circulating concentrations of these two hormones.  
Factors that regulate IGF-I production include thyroid hormones, sex steroids and insulin.  
Leptin secretion can be inhibited by factors such as GH and β-agonists and stimulated by 
insulin, glucose, neuropeptide-Y (NPY) and glucocorticoids.   
________________________ 
This thesis follows the style and format of the Journal of Animal Science. 
 2
 The effect of nutritional intake and BCS and their relation to leptin and IGF-I 
have been previously reported for mares, stallions and geldings.  In addition, the effect of 
the synthetic glucocorticoid dexamethasone (DEX) on leptin secretion in the horse has 
also been determined.  First, both leptin and IGF-I concentrations have been proven to 
correlate positively with BCS in horses and to fluctuate with changes in energy intake.  
Secondly, DEX has been shown to affect an acute increase in leptin secretion with reports 
indicating a possible positive response in IGF-I levels.  Lastly, a sexual dichotomy has 
also been established with geldings and stallions exhibiting greater circulating leptin 
concentrations than mares.  
 Though circulating leptin concentrations and the effect of DEX in stallions and 
geldings have been compared, variations in feeding regimens, body condition and 
sampling schedules have led to conflicting results.  Therefore, the objective of the present 
study was to more clearly define the relationships among body condition, leptin and IGF-
I in stallions and geldings in moderate (5.0-5.5) versus fat (7.0-7.5) body condition with 
the addition of a DEX challenge.  To ensure accurate profiles, horses were fed under 
controlled conditions and analyzed for BCS, rump fat thickness and percent body fat so 
that target BCS could be reached and maintained.  
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CHAPTER II 
REVIEW OF LITERATURE 
Body Condition 
 The evaluation of an animal’s fatness level or body condition scoring (BCS) is a 
subjective method that incorporates visual appraisal usually combined with manual 
palpation of fat reserves.  Methods for condition scoring have been developed for beef 
cattle (Herd and Sprott, 1985), dairy cattle (Wildman et al., 1982) and horses (Henneke et 
al., 1983a).  Body condition scoring, when performed correctly, can be an excellent tool 
in visually determining an animal’s nutritional status.  This information can be used to 
make decisions in relation to production, reproduction, exercise and health.  Though the 
principals for condition scoring are similar, the criteria and the numerical score assigned 
may differ for each species.  Dairy cows are scored on a scale of 1 to 5 with 1 indicating 
poor condition and 5 representing above normal condition with only the rump and back 
being considered for appraisal (Wildman et al., 1982).  In contrast, a larger numerical 
system is utilized when evaluating beef cows and horses.  For these species, a scale of 1 
through 9 is used with 1 representing a poor, or thin condition, and 9 designating obesity 
(Henneke et al., 1983a; Herd and Sprott, 1985).  With regard to evaluation criteria, beef 
cattle are appraised at the shoulder, ribs, loin, and rump (Herd and Sprott, 1985).  Horses, 
on the other hand, are evaluated at the neck, withers, ribs, girth, back, rump and tailhead 
(Henneke et al., 1983a).  In determining the final condition score, all points of interest are 
considered, with no one point being valued above the others (Wildman et al., 1982; 
Henneke et al., 1983a; Herd and Sprott, 1985).  Weight and body size do not correlate to 
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BCS and are not considered when making a final appraisal (Wildman et al., 1982; 
Henneke et al., 1983b; Herd and Sprott, 1985). 
 In addition to visual and tactile appraisal, ultrasonic measurement has become a 
valuable resource in determining an animal’s fat composition .  Ultrasonography has been 
used to determine fatness in cattle (Faulkner et al., 1990; Perkins et al., 1992; Brethour, 
2000) and in horses (Westervelt et al., 1976; Kane et al., 1987).  Westervelt et al. (1976) 
developed a method to correlate ultrasonic measurement to fat deposition in order to 
calculate percent body fat.  It was determined that ultrasonic rump fat measurements 
(taken 5 cm from the midline at the center of the pelvic bone) in horses were positively 
correlated (r = .93) to actual rump fat measured after slaughter (Westervelt et al., 1976).  
In addition, Westervelt et al. (1976) developed an equation (Y + 8.64 + 4.70 X) to 
convert ultrasonic rump fat measurements (X = cm) to actual fat percentage (Y + %).  
Kane et al. (1987) also found that true and ultrasonic rump fat measurements were highly 
correlated in 4 out of 5 measurement sites at the rump.  
 Ultrasonography has also been utilized in correlating BCS to body fat in dairy 
cattle (Domecq et al., 1995) and in horses (Henneke et al., 1983b; Gentry et al., 2004). 
Henneke et al. (1983b) found that percent body fat and body condition correlated 
positively (r = 0.65, P<0.001) after taking ultrasonic rump fat measurements from 32 
mares at different body conditions.  Calculations for percent body fat for this study 
followed the guidelines and calculations set forth by Westervelt et al. (1976).  It has also 
been determined that no correlation exists for weight, height or heart girth in relation to 
percent body fat (Henneke et al., 1983b).  Gentry et al. (2004) also conducted a study to 
correlate BCS to body fat using ultrasonic measurements scanned at the thirteenth rib, 
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withers, tailhead and rump of mares.  It was discovered that correlation coefficients for 
the rump, thirteenth rib, and withers were 0.84, 0.82 and 0.86 with the tailhead 
correlating highest at 0.87 (Gentry et al., 2004).   
 
Leptin 
Leptin is a 14-16 kDa peptide made up of 167 amino acids secreted mainly by 
white adipose tissue.  Through positional cloning, leptin was first described by Zhang et 
al. (1994) as a protein product of the obese (ob) gene.  Early work conducted with the 
ob/ob mouse would conclude that leptin’s primary role is to relay the body’s nutritional 
status to the hypothalamus and to aid in controlling energy homeostasis and body weight 
(Zhang et al., 1994; Halaas et al., 1995; Pellymounter et al., 1995).  
The majority of work originally done to clarify leptin’s actions was conducted 
using obese (ob/ob) mice.  Through parabiosis experiments with ob/ob mice and diabetic 
(db/db) mice, Coleman et al. (1973) concluded that ob/ob mice were unable to synthesize 
a circulating “satiety” factor.  Due to an inability to produce this factor, ob/ob mice 
exhibited obesity and a host of conditions such as hyperphagia, decreased immunity, poor 
thermoregulation, hyperinsulinemia, hypogonadism and infertility (Coleman et al., 1978).  
This illusive satiety factor was later discovered to be leptin. Zhang et al. (1994) identified 
a nonsense mutation in the genetic background of C57BL/6J ob/ob mice.  It was found 
that these mice were unable to produce ob RNA (leptin) (Zhang et al., 1994).  To confirm 
these findings, studies have been conducted in which ob/ob mice were treated with 
exogenous leptin.  Ob/ob mice treated with leptin exhibit a reduction in food intake 
accompanied with reduced body weight, increased thermogenesis, increased metabolism, 
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and reduced insulinemia (Campfield et al., 1995; Halaas et al., 1995; Pelleymounter et 
al., 1995) 
Through expression cloning, the leptin receptor (Ob-R) was initially discovered to 
be located in the mouse choroid plexus (Tartaglia et al., 1995).   Within the same research 
study conducted by Tartaglia et al.(1995), Ob-R was also found to have  homology with 
interleukin-6 (IL-6) receptors and thus was identified as a class I cytokine (Tartaglia et 
al., 1995).  The hypothalamus has been identified in the past as the control center 
regulating body weight and homeostasis, yet the factor linking the brain and the body was 
unknown (Hetherington and Ranson, 1940).  Six splice variants of the Ob-R gene have 
also been identified with the Ob-Rb (long) form being the primary signaling form (Lee et 
al., 1996).  The use of in situ hybridization found the greatest congregation of Ob-Rb to 
be within hypothalamic arcuate, ventromedial, paraventricular and premammillary nuclei 
(Mercer et al., 1996).  Due to its high expression in the hypothalamus, Ob-Rb has been 
determined to be the signaling form that links leptin’s action in the body to the brain (Lee 
et al., 1996; Mercer et al., 1996).  McCann et al. (2003) also concluded that ultimately, 
leptin acts directly on the hypothalamic-pituitary axis by enacting nitric oxide (NO) 
release.   
Though the brain has been the primary focus for leptin receptors, leptin receptors 
have also been discovered in peripheral tissues such as heart, lung, liver, kidney, skeletal 
muscle, adipose tissue, testes and pancreatic β-islets (Tartaglia et al., 1995; Lee et al., 
1996; Emillson et al., 1997).   It has also been determined that leptin in the human is 84% 
identical to murine leptin, 84% identical to bovine leptin and 85% identical to porcine 
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leptin (Zhang et al., 1994; Doyon et al., 2001).  Therefore, results of studies in leptin can 
possibly be applied across species.   
With the discovery of leptin in mice, other studies followed in order to identify 
leptin and its receptors in sheep, cattle, and pigs (Neunschwander et al., 1996; Pfister-
Genskow et al., 1996; Dyer et al., 1997b).  In the equine, Buff et al. (2002) utilized 
reverse transcriptase polymerase chain reaction (RT-PCR) to identify leptin receptor 
mRNA in liver, lung, testis, ovary, choroid plexus, hypothalamus, and subcutaneous 
adipose tissue.  As well as being an “adipostatic” hormone that regulates food intake, 
leptin has been identified as a modulator of other metabolic processes such as 
hematopoesis, bone formation, immunity, angiogenesis, diabetes and fertility (Henson et 
al., 2003).  As early as the 1950s, ob/ob female mice were found to be sterile and unable 
to reproduce (Ingalls et al., 1950; Lane and Dickie, 1954).  Leptin was found to be the 
key as the treatment of female ob/ob mice with recombinant leptin rescued gonadotropin 
secretion, increased secondary sex organ weight and function, and restored fertility 
(Barash et al., 1996; Chehab et al., 1996).  Similar evidence has been obtained in ob/ob 
male mice.  Although some male ob/ob mice can reproduce when fed a restricted diet, the 
majority of male ob/ob mice demonstrate the same sterility condition observed in female 
ob/ob mice (Lane and Dickie, 1954).  Male ob/ob mice exhibit conditions such as low 
testicular weight and low testosterone concentration (Mounzih et al., 1997).  In addition, 
these mice exhibit a combination of few mature sperm cells within the seminiferous 
tubules along with severely atrophied Leydig cells (Mounzih et al., 1997).  Once 
treatment with recombinant leptin was initiated in these mice, testicular weights returned 
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to normal followed by normal Leydig cell function and viable sperm cell production 
(Mounzih et al., 1997).  
Through work with ob/ob mice it has been shown that basic physiological 
similarities exist for individuals of opposing sexes experiencing disturbances in leptin 
secretion.  Despite this fact there is a sexual dimorphism that exists between the male and 
female genders.  In humans, women have been reported to have a fasting serum leptin 
concentration of 15.2 ng/ml compared to 6.9 ng/ml in men (Hickey et al., 1996). Similar 
results have been found in sheep in which ewes have higher circulating leptin 
concentrations than wethers or rams (Blache et al., 2000).  Blache et al. (2000) also 
denoted that adjusting for back-fat thickness could account for only 30% of the variation 
in leptin concentrations seen between genders.  Similar results have been reported for 
leptin differences in humans after adjustment for body mass (Rosenbaum and Leibel, 
1999).  Though leptin concentrations have been found to be higher in human and ovine 
females, the opposite holds true for horses.  In a study to better define peripheral leptin 
concentrations in the horse, Buff et al. (2002) found that leptin concentrations were 
higher in stallions and geldings when compared to mares (P = 0.0002).  
Due to persistent differences in leptin concentrations between genders even after 
adjustment for fat levels, investigators have conducted studies to examine the possibility 
of testosterone acting as the limiting factor.  Numerous studies have suggested the 
likelihood that testosterone can depress circulating leptin concentrations (Blum et al., 
1997; Garcia-Mayor et al., 1997; Mantzoros et al., 1997; Steiner et al., 2003).  Others 
have reported data to refute testosterone’s negative effect on leptin. Piniero et al. (1999) 
denoted no change in leptin secretion from human omental adipose tissue cultured in 
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vitro with testosterone.  Blache et al. (2000) suggested that testosterone might not play as 
large a role in regulating leptin as suspected due to little difference seen in leptin 
concentrations between castrated and intact male sheep.  Taking into account this 
information, the exact interaction of leptin and testosterone is still unclear. 
Some hormones and factors play an agonistic role to enhance leptin secretion 
while other factors play an antagonistic role thus inhibiting leptin’s influence.  Leptin 
secretion can be increased by insulin, glucose, neruopeptide-Y (NPY) and 
glucocorticoids (Barr et al., 1997; Dyer et al., 1997a; Elimam et al., 1998; Mueller et al., 
1998).  Factors that serve to down-regulate leptin synthesis include fasting, decreased 
adiposity, β-agonists and growth hormone (Ahren et al., 1997; Considine and Caro, 1997; 
Houseknecht et al., 2000).  A stimulant of leptin secretion that has gained great attention 
is the synthetic glucocorticoid dexamethasone (DEX).  Considine et al. (1997) found that 
cultured human adipocytes had an 83 + 30% increase in ob mRNA followed by leptin 
secretion when co-incubated with DEX.  In a study conducted by Houseknecht et al. 
(2000), DEX increased leptin mRNA above basal levels when incubated with tissue 
explants from steers. Similarly, DEX treatment has also been found to increase 
circulating leptin concentrations in mares, stallions and geldings after treatment with 
DEX (Cartmill et al., 2003; Cartmill, 2004; Cartmill et al., 2005).  
In the area of nutrition, lower feed consumption and a body mass reduction have 
been shown to produce a negative result on leptin synthesis.  Short and long-term systems 
exist within the body to regulate energy homeostasis and meal intake (Friedman and 
Halaas, 1998).  The short-term system appears to regulate meal intake while the long-
term system governs equilibrium between nutrient accumulation and usage, thus 
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providing energy homeostasis (Friedman and Halaas, 1998).  Leptin has been found to 
operate mainly within this long-term system (Friedman and Halaas, 1998).  In addition, it 
has been revealed that a single meal does not significantly change leptin concentration, 
nor does leptin alone result in limiting food intake (Maffei et al., 1995; Considine et al., 
1996; Dickson et al., 2002).  This calls into question the widely held belief that leptin acts 
as a classic satiety factor (Dickson et al., 2002). 
With the knowledge that nutrient intake can effect leptin secretion, trials have 
been conducted to determine the effects of feed restriction and increased nutrient intake 
on leptin concentrations.  Ahima et al. (1996) discovered that reductions in leptin and 
insulin levels were observed following a 48 h fast in mice. Decreases in circulating leptin 
produce a 23% increase in arcuate neuropeptide –Y (NPY) production signaling to the 
brain the body’s requirement for increased food intake and energy homeostasis 
restoration via hypothalamic pathways (Hahn et al., 1998). During feed restriction, 
cortisol concentrations increase in response to the stress of reduced feed intake and 
declining leptin levels (Bornstein et al., 1997).  The subsequent release of cortisol signals 
to the brain a requirement for increased nutrient intake (Chilliard et al., 2001).  If nutrient 
uptake is initiated, a subsequent stimulation of insulin secretion follows, which under 
high cortisol levels, elicits secretion of leptin (Chilliard et al., 2001).  The rise of leptin 
levels in turn can reduce cortisol release (Bornstein et al., 1997).  In contrast to reduced 
energy stores, increases in adiposity following positive energy intake increases leptin 
levels, signaling the body to reduce feed intake (Dickson et al., 2002).  
Many studies have been conducted in which animals of varying species were 
placed under feed restriction to determine if any effects on leptin secretion existed.  
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Short-term feed restriction in young heifers has been found to cause a decrease in insulin, 
IGF-I, leptin and LH pulses (Amstalden et al., 2000; Williams et al., 2002).  Also, 
McManus and Fitzgerald (2000) conducted a study on aged and young mares to 
determine serum changes in leptin, gonadotropins, prolactin and metabolites.  With both 
aged and young mares in good body condition, short term feed deprivation caused a 
decrease in leptin levels, yet serum levels of LH and FSH were not affected (McManus 
and Fitzgerald, 2000).  An explanation for this observation is that species with a large 
body mass have greater available stores of oxidizable energy to counteract the negative 
response of the hypothalamic-pituitary-gonadal axis to feed reduction (McManus and 
Fitzgerald, 2000).  Though much of the effect of nutrition on leptin has focused on 
nutritional restriction, the effect of nutritional increases on leptin concentrations have also 
been investigated.  Zhang et al. (2004) noted an increase of circulating leptin within 7 h 
of feeding a high energy diet to mature Merino rams.  
Adipocyte size also plays a role in regulating leptin.  Hamilton et al. (1995) found 
that genetic expression of the ob gene was lower in smaller adipocytes when compared 
with larger adipocytes acquired from a single portion of adipose tissue.  In agreement 
with this observation, Lonqvist et al. (1997) discovered that fat cell volume and lipid 
content accounted for 70-80% of variation seen in circulating leptin between obese and 
non-obese women.  Fasting can reduce adipose tissue volume resulting in a decrease in 
leptin as opposed to an increase in leptin concentrations seen with increases in adipose 
tissue mass (Maffei et al., 1995; Considine and Caro, 1997; Friedman and Halaas, 1998).  
The overall fatness of an animal, or body condition, has been found to be a good 
indicator of circulating leptin concentrations.  Body condition has been found to be 
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positively correlated with leptin levels in cattle (Delevaud et al., 2000) and sheep (Yildiz 
et al., 2003).  Comparison of individuals within the same species confirms the difference 
in leptin between individuals of high and low BCS.  In an experiment conducted by Buff 
et al. (2002), leptin levels were positively correlated to body condition score (BCS) based 
upon the condition scoring system set forth by Henneke et al. (1983a).  Serum leptin was 
found to be higher in horses of fleshier body condition when compared to their thinner 
counterparts (Buff et al., 2002).  These results were confirmed by Gentry et al. (2002a) 
who found that mares with a high BCS (7.5-8.5) had higher circulating levels of leptin, 
IGF-I, and luteinizing hormone (LH) compared to mares in low body condition (3.0-3.5). 
Thus leptin concentrations can fall into two categories; (1) lower levels with lower 
numbers of adipocytes and (2) higher levels following an increase in adipocyte stores 
(Considine, 2003).  
 
Insulin-like Growth Factor-I 
Insulin-like growth factors are “growth promoting” polypeptides weighing 7.5 
kDa that are secreted mainly by the liver and are controlled by the body’s nutritional state 
and by other hormones (Phillips et al., 1990; Thissen et al., 2006).  Rinderknecht and 
Humbel (1978) found the sequence of IGF-I to have 48% similarity with human 
proinsulin and thus coined the term “insulin-like”.  The principal role of IGF-I is to 
mediate growth hormone’s (GH) effect on the skeletal system (Phillips and 
Vassilopoulou-Sellin, 1980a,b) and growth hormone has been found to elicit a response 
in IGF-I secretion from the liver (Jones and Clemmons, 1995).  The majority of IGF-I in 
circulation (80%) is bound to IGF-binding protein-3 (IGFBP-3) with the remainder of 
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IGF-I in the “free/dissociable” state (Jones and Clemmons, 1995; Bereket et al., 1996).  
Other factors including thyroid hormones, insulin, sex steroids and nutrition can regulate 
IGF-I production (Philips et al., 1990; Buonomo and Baile, 1991). 
 Since GH can stimulate IGF-I secretion, it would logically be assumed that an 
increase in GH would be paralleled by a subsequent rise in IGF-I levels.  In swine and 
sheep, feed restriction has been found to increase the amount of GH in plasma (Thomas 
et al., 1990; Buonomo and Baile, 1991; Yambayamba et al., 1996).  Despite an increase 
in GH concentration during feed restriction, GH receptors and IGF-I concentration in 
plasma are decreased (Breier, 1999).  Philips et al. (1990) found that IGF-I concentrations 
fell in fasted rats with a restoration of IGF-I concentrations after refeeding.  Other studies 
have also shown that IGF-I levels consequently decrease with reductions in energy 
availability in humans (Musey et al., 1993), swine (Buonomo and Baile, 1991), sheep 
(Thomas et al., 1990) and cattle (Richards et al., 1991; Leon et al., 2004; Lents et al., 
2005).  The relationship between nutrient intake and IGF-I concentrations has also been 
investigated in the horse.  Sticker et al. (1995) reported that mares fed a diet with energy 
reduced to 50% below maintenance levels had lower levels of IGF-I compared to mares 
on a control diet (100% of energy required for maintenance).  Gentry et al. (2002a,b) 
found that mares in high BCS had greater levels of plasma IGF-I than mares in low BCS.  
 Reports also indicate the possibility that DEX treatment can positively stimulate 
IGF-I production.  Ajuwon et al. (2003) discovered that porcine hepatocytes cultured in 
vitro with DEX caused a significant increase in IGF-I concentrations.  Cartmill et al. 
(2003) noted a similar in vivo effect of DEX on IGF-I in horses.  In this study, rises in 
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IGF-I levels after DEX injection were detected on d 12 and 19 relative to treatment in 
geldings, and on d 10, 12 and 19 in mares (Cartmill et al., 2003). 
 
 
Interaction of Leptin and IGF-I 
 In many studies reporting the effect of nutrient intake on leptin, circulating leptin 
and IGF-I concentrations have mirrored one another. Both hormones exhibit lower 
concentrations subsequent with low BCS and feed restriction as opposed to higher 
concentrations in both hormones during positive energy balance and body fat levels.  The 
parallel changes detected in leptin and IGF-I have led to the hypothesis that the two 
hormones may somehow directly influence one another.  
 To test this hypothesis, experiments have been conducted in which adipocytes 
have been cultured in vitro with IGF-I.  Hardie et al. (1996) harvested mature adipocytes 
from epidydimal fat pads in male Zucker rats and cultured the adipocytes in vitro with 
IGF-I and GH.  Neither IGF-I nor GH stimulated any response in leptin secretion from 
the cultured adipocytes (Hardie et al., 1996).  Similar results have been obtained from in 
vivo studies using ”fatty” Zucker rats.  Zucker rats infused with IGF-I (200 µg/kg/day) 
exhibited no change in body fat percentage or the amount of leptin mRNA (Isozaki et al., 
1999).   
Similarly, studies have also been conducted to determine if leptin is responsible 
for the increases seen in circulating IGF-I.  In 1998, Barb et al. conducted an experiment 
to test the effects of recombinant porcine leptin on GH and IGF-I in gilts.  No effect on 
either GH or IGF-I was detected after 10, 50, and 100 µg doses were administered (Barb 
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et al., 1998).  Human studies have also revealed a lack of relationship between leptin and 
IGF-I concentrations (Janssen et al., 1998; Gomez et al., 2003).   
 Contrary to these findings, Ajuwon et al. (2003) found that at low doses, leptin 
reduced serum IGF-I concentrations dose-dependently and blocked hepatic IGF-I 
production.  Also, Houseknecht et al. (2000) reported that leptin concentrations were 
positively correlated to the amount of IGF-I mRNA detected in adipose tissue from cattle. 
Taken together, the information presented reveals that a relationship between IGF-I and 
leptin, either direct or indirect, is complex and still unclear.  
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CHAPTER III 
MATERIALS AND METHODS 
 
Management of Horses 
 Five mature stallions and five geldings, of Stock Horse and Thoroughbred 
breeding, were used for the purposes of this study (Appendix Table 7A).  All horses used 
in this study were property of the Texas A&M University Department of Animal Science 
and were maintained at the Texas A&M University Horse Center and N.W. Freeman 
Arena. Maintenance of the horses for this study conformed with guidelines set forth by 
the Institutional Agricultural Animal Care and Use Committee (AUP# 2005-252).  
 Horses were housed in 10’ X 10’ stalls and paddocks with access to regulated 
exercise to maintain the required BCS for each animal.  Diets were adjusted accordingly 
to obtain and subsequently maintain the desired body condition for each horse.  Meals for 
each horse were administered in accordance with the current ration utilized for each horse 
by the Texas A&M University Horse Center.  This ration included a commercially 
produced concentrate (Producer’s Cooperative Association, Bryan, TX) containing 13% 
crude protein.  Horses were also fed coastal bermudagrass hay and were provided ad 
libitum access to water.  All feedings were conducted at 0630 and 1730 daily. 
 
Physical Measurements 
 All horses were initially evaluated for BCS utilizing the consensus of at least two 
objective observers beginning October 10, 2005.  At this time, each horse was grouped 
into the appropriate BCS group to which it most closely fit.  Concordantly, each horse 
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was weighed and rump fat measurements were taken using ultrasonic scanning 
equipment with a 5MHz transducer (Medison SonoVet 600®, Universal, Bedford Hills, 
NY.).  Rump fat measurements were taken from an area measuring 10.00 cm from the 
point of the hip and 5.00 cm from the midline.  The purpose of this measurement was to 
correlate fat deposition, or removal, to BCS.  Following initial observations, each horse’s 
diet was adjusted to ensure that the proper BCS group for each horse was obtained.  
 Once target BCS was met, week one of the initial trial began on November 7, 
2005. Weight and rump fat measurements were taken on a weekly basis throughout both 
trial periods and every other week during the transition period.  Weights and rump fat 
measurements for each horse were taken on the same day.  Body condition score 
evaluations were conducted every two weeks throughout the entire project with the aid of 
at least two objective observers.  
 
Experimental Design 
 A switchback design was utilized to maximize observations for all groups 
(gelding vs. stallion, BCS 5.0 vs. BCS 7.0).  Each horse from one of the two male 
categories was initially evaluated and placed in an appropriate treatment group.  The trial 
began initially with five horses (two stallions, three geldings) in BCS of 7.0 and five 
horses (three stallions, two geldings) in BCS of 5.0.  Following the first 29 day blood 
collection period (beginning Nov. 7 and ending on Dec. 5, 2005), each horse’s diet was 
adjusted to achieve the alternate body condition.  Once the desired BCS was obtained, the 
second blood collection period began on March 7, 2006 with five horses (three stallions, 
two geldings) in BCS of 7.0 and five horses (two stallions, three geldings) in BCS of 5.0.  
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The adjustment period required approximately 12 weeks beginning on December 6, 2005 
and ending on March 6, 2006.  
 
Plasma Sampling 
  Blood was collected from each horse using jugular venipuncture on d -2, -1, 0, 1, 
2, 3, 4, 5, 12, 19, and 26 for laboratory analysis.  Blood samples were obtained at 0600 
before feeding to minimize fluctuation in circulating hormones.  On d 0, a single 
intravenous injection of DEX was administered to each horse after blood samples were 
collected.  Each DEX dosage was concordant with the test subject weight (.045 mg/kg 
BW). Upon collection, all blood samples were stored on ice in preparation for 
centrifugation. All samples were centrifuged within 1 h of collection in a refrigerated 
centrifuge. Centrifuge temperature was set for 5°C and samples were spun at 2500 x G 
for 30 min. Once centrifuged, plasma was stored in microcentrifuge tubes at -20°C for 
later analysis.  
 
Radioimmunoassay (RIA) Procedures 
 Plasma concentrations of leptin (McManus and Fitzgerald, 2000) and IGF-I 
(Sticker et al., 1995) were analyzed utilizing RIA as previously documented for horse 
samples.  Leptin and IGF-I RIA kits were provided with all reagents required for 
completing each assay.  Leptin and IGF-I assays were analyzed using a Packard Cobra 
II® gamma counter.  All samples from each horse were analyzed in a single assay for 
each hormone.  All assay samples for each horse were run in duplicate with standards and 
reagents being run in triplicate.  
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 Plasma leptin concentrations were measured using a multispecies leptin RIA kit 
(Linco Research, Inc., St. Charles, MO).  A sample volume of 100 µl was used with a 
sensitivity of 1.0 ng/ml. Plasma leptin intra-assay coefficient of variation (CV) was 6.2% 
and inter-assay CV was 16.6% (n = 7 assays). 
 Plasma IGF-I concentrations were measured using an RIA kit (Diagnostic 
Systems Laboratories, Inc., Webster, TX).  A sample volume of 50 µl was used with a 
sensitivity of 0.8 ng/µl. Plasma IGF-I intra-assay CV was 7.8% and inter-assay CV was 
6.0% (n = 7 assays).  
 
Statistical Analyses 
 Data from BCS, rump fat thickness and body fat percentage were analyzed by 
analysis of variance (ANOVA) using STATA 8 statistical analysis software (Stata Corp., 
College Station, TX).  Each parameter was also analyzed for group effects (BCS 5 vs. 
BCS 7 and stallions vs. geldings), and period effect.   
 Plasma leptin and IGF-I were analyzed using piecewise regression.  A structural 
time break was modeled in order to assess the effect of the DEX challenge on hormone 
concentrations.  Where necessary, data for each horse were normalized to baseline (d 0) 
values in order to better characterize changes from baseline.  Data from leptin and IGF-I 
concentrations were also analyzed for day effect, period effect, and group effects by 
ANOVA. 
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CHAPTER IV 
RESULTS 
Body Condition 
 Body condition evaluations were performed semi-monthly on both stallions and 
geldings insuring that both castrate and intact males were correctly grouped by the body 
condition to which they were designated.  Body condition evaluations were also 
performed to maintain a significant difference between the fat and moderate groups.  It 
should be noted that due to unforeseen circumstances, one stallion was removed from the 
study during the second trial period.  Horses in the fat group achieved a mean BCS of 6.3 
+ 0.2 whereas horses in the moderate group achieved a mean BCS of 5.3 + 0.1 (Table 1).  
Though the horses for the fat group did not achieve a mean body condition level of 7.0, 
analysis of body condition evaluations revealed a difference between both fat (BCS 7.0) 
and moderate (BCS 5.0) groups (P<0.001).  Weekly rump fat measurements were also 
taken and converted to percent body fat to correlate BCS to body fat percentage.  Weekly 
rump fat measurements and percent body fat analyses also showed a difference (P<0.05) 
between groups.  Mean rump fat for the moderate group was 1.1 + 1.5 cm versus 1.6 + 
1.2 cm for the fat group (Table 1).  A greater rump fat measurement translated into a 
higher body fat percentage.  This was illustrated by mean body fat percentage for the fat 
group of 16.2 + 0.6% compared to a mean body fat percentage of 14.0 + 0.7% for the 
moderate group (Table 1).  The difference in means for rump fat and percent body fat 
between the fat and moderate groups further demonstrated that BCS groups were 
significantly different.  No period effect was evident as mean body condition scores, 
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rump fat thickness and body fat percentage were not significantly different within each 
BCS group between the first and second periods.  
 Differences between stallions and geldings were also investigated.  No sex effect 
was detected for BCS, rump fat thickness or percent body fat between geldings and 
stallions within each BCS group.  Geldings in the fat group had a mean BCS of 6.4 + 0.3 
with stallions revealing a mean BCS of 6.1 + 0.3 (Table 2).  In comparison, geldings in 
the moderate group had a mean BCS of 5.4 + 0.1 while stallions held a mean BCS of 5.3 
+ 0.1 (Table 2).  Though the percent body fat and rump fat thickness tended to be higher 
for geldings, there was no significant difference between either measurement for both 
groups.  
 
 
Table 1. Mean (+ SE) body condition, rump fat thickness, and percent body fat of fat- vs. 
moderate-conditioned groups for periods 1 and 2. 
Group n BCS Rump Fat (cm) % Body Fat 
Fat     
Period 1: 5 6.2a + 0.3 1.6c + 1.2 16.0c + 0.6 
Period 2: 4 6.4a + 0.2 1.7c + 2.5 16.5c + 1.2 
Overall Total:  6.3a + 0.2 1.6c + 1.2 16.2c + 0.6 
Moderate     
Period 1: 5 5.2b + 0.2 0.8d + 2.0 12.6d + 1.0 
Period 2: 5 5.5b + 0.1 1.4d + 1.6 15.3d + 0.7 
Overall Total:  5.3b + 0.1 1.1d + 1.5 14.0d + 0.7 
a,b Means within column lacking common superscripts differ (P<0.001) 
c,d Means within column lacking common superscripts differ (P<0.05) 
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Table 2. Mean (+ SE) body condition, rump fat thickness and percent body fat of 
geldings vs. stallions in fat and moderate BCS groups. 
Group n BCS Rump Fat (cm) % Body Fat 
Fat     
Geldings: 5 6.4a + 0.3 1.8c + 1.1 17.8c + 1.1 
Stallions: 4 6.1a + 0.3 1.4c + 2.0 14.0c + 2.0 
     
Moderate     
Geldings: 5 5.4b + 0.1 1.2d + 0.7 12.2d + 0.7 
Stallions: 5 5.3b + 0.1 1.0d + 3.1 10.4d + 3.1 
     
a,b Means within column lacking common superscripts differ (P<0.001) 
c,d Means within column lacking common superscripts differ (P<0.05) 
 
 
Hormone Analyses: Plasma Leptin 
 Mean plasma leptin concentration over the entire trial indicated that the fat group 
was 2.13 + 0.1 ng/ml which was different (P<0.001) from a mean plasma leptin 
concentration of 1.44 + 0.1 ng/ml for the moderate group (Table 3).  It should be noted 
that analysis of leptin was initially conducted investigating only the difference between 
BCS groups.  As there was a difference for leptin concentrations between the BCS 
groups, the difference between castrate and intact males was analyzed within BCS groups 
rather than between BCS groups.  With regards to castrate versus intact males there was 
no significant difference between stallions and geldings as mean plasma leptin was 1.84 + 
0.1 ng/ml for stallions and 1.70 + 0.1 ng/ml for geldings (Table 4).  These values are 
slightly lower than the 3.37 + 0.38 ng/ml for geldings and 3.50 + 0.45 ng/ml for stallions 
reported by Buff et al. (2002).  
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Table 3. Mean (+ SE) plasma leptin concentrations (ng/ml) for horses 
in moderate vs. fat BCS groups by day. 
Day BCS 5  BCS 7 
-2 1.46 + 0.3  2.06 + 0.3 
-1 1.32 + 0.3  1.92 + 0.4 
0 1.36 + 0.2  2.18 + 0.4 
1 1.66 + 0.2  3.66 + 0.8 
2 1.62 + 0.2  2.80 + 0.5 
3 1.37 + 0.1  1.67 + 0.2 
4 1.38 + 0.1  1.76 + 0.4 
5 1.75 + 0.3  1.91 + 0.3 
12 1.33 + 0.2  1.82 + 0.3 
19 1.40 + 0.2  2.03 + 0.3 
26 1.22 + 0.2  1.60 + 0.2 
Overall Total 1.44a + 0.1  2.13b + 0.1 
a,b Means between columns lacking common superscripts differ (P<0.001) 
 
Table 4. Mean (+ SE) plasma leptin concentrations (ng/ml) for stallions 
vs. geldings by day. 
Day Stallions  Geldings 
-2 1.98 + 0.3  1.53 + 0.3 
-1 1.73 + 0.3  1.49 + 0.4 
0 2.00 + 0.4  1.52 + 0.3 
1 2.44 + 0.5  2.76 + 0.7 
2 2.10 + 0.3  2.25 + 0.5 
3 1.53 + 0.2  1.50 + 0.2 
4 1.50 + 0.2  1.61 + 0.3 
5 2.02 + 0.4  1.64 + 0.2 
12 1.63 + 0.3  1.50 + 0.2 
19 1.70 + 0.3  1.69 + 0.3 
26 1.66 + 0.2  1.17 + 0.2 
Overall Total 1.84 + 0.1  1.70 + 0.1 
 
 
Due to initial variability in circulating concentrations of leptin between the two 
BCS groups, the data were normalized by subtracting leptin concentrations for each horse 
from baseline values.  Regression analysis indicated that leptin concentration in response 
to the DEX challenge was different (P<0.05) between the fat and moderate groups with 
the fat group being higher (Figure 1).  There was no effect of period, however, there was 
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an effect of day (P<0.001).  DEX treatment on d 0 resulted in a rise in plasma leptin 
concentration within 24 h for both groups (Figure 1).  Though leptin concentrations 
began to decrease following d 1, leptin concentrations remained different (P<0.05) 
between the two groups with leptin concentrations for both groups returning to baseline 
levels by d 5 (Figure 1). 
 
  
 
-0.4
-0.2
0
0.2
0.4
0.6
0.8
1
0 1 2 3 4 5 12 19 26
Days
Le
pt
in
 (n
g/
m
l)
BCS 5 BCS 7a b
 
Figure 1. Regression analysis of change in plasma leptin concentrations  
           between horses in moderate vs. fat BCS groups after DEX treatment. a,b Groups  
           not sharing common superscripts differ (P<0.05) 
 
    
 In relation to stallions versus geldings, no significant difference was detected 
when comparing the change in plasma leptin concentrations.  An increase in plasma 
leptin concentration was detected for both stallions and geldings within 24 h of DEX 
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treatment on d 0 (Figure 2).  Leptin concentrations began to decrease after d 1 returning 
to baseline levels on d 5 (Figure 2).   
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Figure 2. Regression analysis of change in plasma leptin concentrations  
           between stallions vs. geldings after DEX treatment.  
 
  
Hormone Analyses: Plasma IGF-I  
Regression analysis of IGF-I revealed that IGF-I did not respond to the DEX 
challenge nor did it change by day. Therefore, plasma IGF-I data were analyzed by 
ANOVA.  Mean plasma IGF-I concentration over the entire trial indicated no significant 
difference between BCS groups as plasma IGF-I concentration for the fat group was 
347.2 + 11.4 ng/ml versus a mean plasma leptin concentration of 344.3 + 10.0 ng/ml for 
the moderate group (Table 5).  Insulin-like growth factor-I concentrations were different 
(P<0.05) between geldings and stallions with the geldings having higher plasma IGF-I 
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concentrations.  Mean plasma IGF-I was 329.1 + 12.1 ng/ml for stallions while the 
geldings achieved a mean plasma IGF-I concentration of 360.5 + 9.1 ng/ml (Table 6).  No 
effect of period was detected.  
 
Table 5. Mean (+ SE) plasma IGF-I concentrations (ng/ml) for horses 
 in moderate vs. fat BCS groups by day. 
Day BCS 5  BCS 7 
-2 314.0 + 34.6  353.0 + 41.3 
-1 322.8 + 30.5  334.6 + 33.0 
0 322.7 + 42.0  339.3 + 45.5 
1 368.7 + 31.8  353.4 + 40.5 
2 383.8 + 37.4  366.6 + 42.9 
3 339.7 + 34.1  366.4 + 37.3 
4 378.7 + 36.9  352.1 + 36.0 
5 329.0 + 34.7  354.0 + 45.4 
12 330.9 + 31.2  327.5 + 32.8 
19 355.1 + 31.3  354.2 + 39.5 
26 340.2 + 28.2  320.0 + 40.4 
Overall Total 344.3 + 10.0  347.2 + 11.4 
 
 
Table 6. Mean (+ SE) plasma IGF-I concentrations (ng/ml) for stallions  
vs. geldings by day. 
Day Stallions  Geldings 
-2 312.5 + 41.9  350.5 + 34.1 
-1 306.5 + 36.0   348.1 + 26.0 
0 306.0 + 47.0  352.6 + 39.4 
1 354.0 + 39.7  368.2 + 32.7 
2 356.4 + 44.9  392.0 + 35.3 
3 330.0 + 42.5  372.4 + 27.9 
4 344.5 + 47.0  385.5 + 24.1 
5 345.0 + 42.8  338.1 + 38.2 
12 304.7 + 33.7  351.4 + 28.5 
19 343.8 + 41.5  364.4 + 28.7 
26 319.5 + 42.8  340.6 + 25.2  
 Overall Total 329.1a + 12.1  360.6b +   9.1 
a,b Means between columns lacking common superscipts differ (P<0.05) 
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CHAPTER V 
DISCUSSION 
Body Condition 
 Both geldings and stallions were fed under controlled conditions and monitored to 
ensure that the proper BCS group to which each horse was assigned could possibly be 
achieved.  Steps were also taken in designing the experiment to reduce the possibility of a 
period effect by grouping stallions and geldings together within a respective BCS group 
in a switchback design.  
 Body condition was evaluated by at least two objective individuals in accordance 
with BCS guidelines set forth by Henneke et al. (1983a).  Statistical analysis of BCS 
revealed that horses designated for the fat (BCS 7.0) group had a mean BCS of 6.3 + 0.2. 
Despite efforts to control conditions and feed intake, the horses in the fat group came in 
under the target BCS.  This could be due to the fact that some individual horses may have 
required longer than the allotted 12 wk transition period to fully attain the appropriate 
BCS.  As well, some of the horses used in this study may never have (due to physiology, 
breed type, etc.), been able to fully attain a BCS of 7.0 despite all efforts.  Obviously, 
these individuals would ultimately lower the mean BCS for the fat group.  It should be 
noted that all horses used in this study were healthy and experienced no insults to 
physical condition that would have made depositing fat a more arduous process.  In 
contrast, horses assigned to the moderate (BCS 5.0) group performed well as the mean 
BCS for the moderate group was 5.3 + 0.1.  Despite the fact that a mean BCS of 7.0 was 
not achieved by the fat group, body condition analysis indicated a difference (P<0.001) 
between the two BCS groups.  
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 In addition to BCS evaluations, weekly rump fat scans were performed with the 
use of ultrasonography and later converted to percent body fat using the conversion 
equation set forth by Westervelt et al. (1976).  Studies have shown that ultrasonic rump 
fat measurements correlate positively to percent body fat in horses (Westervelt et al., 
1976; Kane et al., 1987).  Ultrasonography has also been used to positively correlate 
percent body fat to body condition (Henneke et al., 1983b; Gentry et al., 2004). The 
results of this study concur with the previous findings.  Analysis of rump fat and percent 
body fat data revealed a difference (P<0.05) between BCS groups. Mean rump fat and 
percent body fat for the fat group were 1.6 + 1.2 cm and 16.2 + 0.6% respectively.  The 
same analysis for the moderate group revealed a mean rump fat of 1.1 + 1.5 cm and mean 
percent body fat of 14.0 + 0.7%.  Greater rump fat measurements translate into greater 
percent body fat and ultimately a higher BCS. Therefore, the data served to confirm the 
difference seen between BCS groups.  
 In addition to analysis of overall BCS groups, the difference between stallions and 
geldings was also investigated.  No sex effect was evident as there was no significant 
difference detected between stallions and geldings.  Geldings within the fat group 
achieved a mean BCS of 6.4 + 0.3 with the stallions achieving a mean BCS of 6.1 + 0.3.  
For the moderate group, geldings held a mean BCS of 5.4 + 0.1 with the stallions holding 
a mean BCS of 5.3 + 0.1.  Lastly, data were analyzed to determine if any period effect 
existed.  The results showed that there was no period effect as there was no significant 
difference for rump fat or body fat percentage within each BCS group between the first 
and second periods. 
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Leptin 
 Leptin is an adipocyte hormone that serves to maintain energy homeostasis and 
body weight by relaying the body’s nutritional state to the hypothalamus (Zhang et al., 
1994; Halaas et al., 1995; Pellymounter et al., 1995).  As a hormone secreted mainly by 
adipose tissue, it is logical to conclude that changes in nutrition and body fat can 
influence the levels of leptin secreted.  Studies have shown that increases or reductions in 
feed consumption can have a positive or negative effect on leptin concentrations (Ahima 
et al., 1996; Dickson et al., 2002).  Consequently, the overall size and volume of 
individual adipocytes, which indicate the body’s degree of fatness, can also influence 
circulating leptin concentrations (Lonqvist et al., 1997).  Taken together, changes in 
energy intake can influence body condition thereby influencing leptin secretion (Mafei et 
al., 1995; Considine and Caro, 1997; Friedman and Halaas, 1998).  
 Plasma leptin has been positively correlated to BCS in sheep (Yildiz et al., 2003) 
and cattle (Delevaud et al., 2000).  A positive relation between body condition and leptin 
has also been shown to exist in the horse (Buff et al., 2002).  Furthermore, a sexual 
dichotomy exists within the horse as circulating leptin concentrations are typically higher 
in stallions and geldings when compared to mares in similar BCS (Buff et al., 2002; 
Cartmill, 2004).  In agreement with previous studies, the present study also shows a 
positive correlation between BCS and plasma leptin concentrations.  Mean plasma leptin 
concentrations overall were different as mean plasma leptin was 2.13 + 0.1 ng/ml for the 
fat group versus 1.44 + 0.1 ng/ml for the moderate group (P<0.001).  After normalizing 
the data to account for initial variability, the change in leptin concentrations seen in 
response to the DEX challenge again revealed a significant (P<0.05) difference between 
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BCS groups.  Dexamethasone (DEX) has been proven to increase circulating leptin 
concentrations in humans (Considine et al., 1997), cattle (Houseknecht et al., 2000) and 
horses (Cartmill et al., 2003; Cartmill, 2004; Cartmill et al., 2005).  The current data 
confirm these findings as a day effect was detected for circulating leptin (P<0.001).  Both 
BCS groups experienced a 24 h rise in circulating leptin after treatment with DEX with 
horses in the fat BCS group experiencing a greater increase in circulating leptin 
concentrations compared to the moderate BCS group.  The day effect was a direct result 
of the concomitant rise in leptin concentrations seen within 24 h of DEX treatment.  This 
same rise was also seen in analysis of stallions and geldings with both groups exhibiting 
the same 24 h increase in circulating leptin concentrations seen with BCS group analysis.  
 Comparison of circulating leptin concentrations between stallions and geldings 
has previously been reported with geldings exhibiting higher leptin concentrations 
(Cartmill, 2004).  Differences for leptin concentrations between geldings and stallions 
were also investigated within the present study with no significant difference in leptin 
concentrations seen between stallions and geldings within the same BCS group.  These 
results differ from results observed by Cartmill (2004) and are in agreement with 
published data by Buff et al. (2002) who also saw no difference in leptin concentrations 
between stallions and geldings.  The results for stallions and geldings noted by Buff et al. 
(2002) were slightly higher than the values for stallions and geldings reported in the 
present study.  This could possibly be a result of the difference in RIA kits used between 
the studies.  It should also be noted that in the study conducted by Cartmill (2004), 
stallions and geldings were not fed alike nor were they assigned to similar BCS groups.  
Geldings had a greater BCS of 6.6 + 1.4 with stallions in an average BCS of 4.9 + 1.0 
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(Cartmill, 2004). This would explain the contradiction between reports for stallions and 
geldings as the horses used in the present study were fed and maintained under controlled 
conditions as well as being assigned to similar BCS groups. It has also been postulated 
that testosterone may not play quite the antagonistic role on leptin previously thought 
(Blache et al., 2000).  With no difference seen in leptin concentrations between stallions 
and geldings of similar BCS, the same conclusion could also be drawn from the current 
data.   
 
IGF-I 
 Insulin-like growth factor-I (IGF-I) is a 7.5 kDa polypeptide that is secreted 
primarily from the liver and is regulated by growth hormone (GH) and nutritional state as 
well as other factors and hormones (Phillips et al., 1990).  As with leptin, publications 
addressing IGF-I have reported reductions in IGF-I concentrations during feed restriction 
(Breir, 1999) and with subsequent increases in IGF-I after nutrient intake (Phillips et al., 
1990).  Insulin-like growth factor-I concentrations have also been correlated to BCS as 
differences in circulating IGF-I were noted between mares in high versus low BCS 
(Gentry et al., 2002a,b).  
 In the present study, no significant difference for IGF-I concentration was noted 
between BCS groups. Overall mean plasma IGF-I concentrations were 347.2 + 11.4 
ng/ml for the fat group versus 344.3 + 10.0 ng/ml for the moderate group.  This result 
could possibly be explained by the fact that even though BCS groups were deemed 
significantly different in the physical data, the difference may not have been large enough 
to effect significant differences in IGF-I concentrations.  
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 Though no significant difference was detected for IGF-I concentrations between 
groups, there was a significant difference (P<0.05) detected for IGF-I concentrations 
between stallions and geldings.  Geldings were found to have higher circulating IGF-I 
with an overall mean plasma concentration of 360.5 + 9.1 ng/ml compared to 329.1 + 
12.1 ng/ml in stallions.  These results differ from prior research conducted to investigate 
the difference in circulating IGF-I between stallions and geldings.  Champion et al. 
(2002) found that stallions exhibited higher concentrations of IGF-I (307.4 + 26.9 ng/ml) 
than did geldings (249.2 + 5.3 ng/ml).  The hypothesis was that a stallion’s higher 
testosterone profile is somehow connected to the difference observed in IGF-I 
concentrations.  With IGF-I concentrations in the current study being higher in geldings, 
it is possible that testosterone may not be responsible for stimulating IGF-I secretion.  
Since no other hormonal profiles were performed in the present study, further research is 
warranted to determine a specific factor responsible for the difference in IGF-I 
concentrations between stallions and geldings. 
Unlike the results for leptin, DEX treatment did not produce any acute effects on 
circulating IGF-I in any of the groups, as there was no significant difference between 
days.  Insulin-like growth factor-I has been reported to positively correlate to rising leptin 
levels in cattle (Houseknecht et al., 2000).  Since there was no significant difference in 
IGF-I during the trial as was noted in leptin, it is possible that there is not a consistent 
relationship between circulating leptin and IGF-I.  
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CHAPTER VI 
SUMMARY 
 In the present study, the analysis of stallions and geldings in either a fat (BCS 7.0) 
or moderate (BCS 5.0) condition suggests that plasma leptin is possibly more sensitive to 
smaller changes in BCS than is circulating IGF-I.  Physical measurements (BCS, rump 
fat thickness, percent body fat) that are proven indicators of body fatness and effectors of 
the hormones assayed were collected and analyzed.  This was done to ensure a clear 
understanding of the relation of hormonal profiles to the groups studied. 
 Leptin is an adipocyte hormone that has been firmly established as a modulator of 
the body’s fat stores via the hypothalamic-pituitary-axis.  Insulin-like growth factor-I has 
also been proven to relate closely with nutrition and body fatness as circulating IGF-I 
concentrations can be positively or negatively affected by changes in diet and body 
condition. 
 Leptin levels were shown in the present trial to correlate positively with body 
condition, yet no sex effect was evident as leptin levels varied little between castrate and 
intact males.  These data serve to confirm previously published data that leptin is closely 
associated with BCS and changes in adiposity.  Earlier studies have shown a difference in 
leptin profiles between castrate and intact male horses with geldings being relatively 
higher.  Due to little variation noted between stallions and geldings in the present study, 
the role of testosterone as a leptin antagonist can be called into question. 
 Insulin-like growth factor-I profiles indicated that BCS within the range studied 
had little influence on circulating IGF-I.  This can possibly be explained by the fact that 
despite a significant difference observed between BCS groups, all horses were in good 
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body condition (BCS > 5).  In previous studies, animals exhibiting differences in IGF-I 
profiles were primarily in poor versus good body condition.  Had the horses in the present 
study been separated more widely by BCS, a difference in circulating IGF-I may have 
been seen.  In relation to the difference between castrate and intact males, there was a 
significant difference detected with geldings having higher circulating IGF-I.  These 
finding conflict with previously published data, and since no other hormonal profiles 
beyond leptin and IGF-I were taken, the reason for this difference cannot be concluded. 
 Dexamethasone has been shown to stimulate leptin secretion, and has been found 
in some reports to also positively effect IGF-I secretion.  The present trial was found to 
be in agreement with previous findings as regression analysis of leptin indicated a day 
effect indicatory of the rise in leptin seen after DEX treatment.  A similar rise was not 
seen in the IGF-I profile, therefore it could not be concluded from these data that DEX 
has any effect of circulating IGF-I.  Due also to the differences in day effects seen 
between the two hormones presently studied a direct effect between leptin and IGF-I 
could not be concluded.   
The data analyzed and presented in this experiment have provided a more 
accurate profile of leptin and IGF-I between geldings and stallions in moderate and fleshy 
body condition.  Also, the analysis and results from this trial can be used to increase the 
knowledge base of equine endocrinology above that which was previously available.  
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Appendix Table 1A. ANOVA table for body condition score. 
 
Source DF Partial SS Mean Square F Value Pr>F 
      
Model 3 4.49147493 1.49715831 6.31 0.0055 
Period 1 .238235446 .238235446 1.00 0.3322 
Group 1 4.2024719 4.2024719 17.72 0.0008 
Sex 1 .062235175 .062235175 0.26 0.6160 
Residual 15 3.55799928 .237199952   
      
Total 18 8.04947421 .447193012   
 
 
 
 
Appendix Table 2A. ANOVA table for rump fat thickness. 
 
Source DF Partial SS Mean Square F Value Pr>F 
      
Model 3 201.544079 67.1813596 4.40 0.0207 
Period 1 56.4183824 56.4183824 3.69 0.0738 
Group 1 111.265441 111.265441 7.29 0.0165 
Sex 1 30.3007353 30.3007353 1.98 0.1794 
Residual 15 229.0875 15.2725   
      
Total 18 430.631579 23.9239766   
 
 
 
 
Appendix Table 3A. ANOVA table for body fat percentage. 
 
Source DF Partial SS Mean Square F Value Pr>F 
      
Model 3 44.2539734 14.7513245 4.36 0.0214 
Period 1 12.2550076 12.2550076 3.62 0.0765 
Group 1 24.3291303 24.3291303 7.18 0.0171 
Sex 1 6.84724332 6.84724332 2.02 0.1755 
Residual 15 50.8028782 3.38685854   
      
Total 18 95.0568515 5.2809362   
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Appendix Table 4A. Normalized regression table for plasma leptin between groups. 
 
Source DF Partial SS Mean Square 
    
Model 6 20.2664512 3.37774187 
Residual 165 97.3474012 .58998425 
    
Total 171 117.613852 .687800307 
 
Leptin Coef. Std. Error t P> [t] 
     
Day -.4192323 .1460869 -2.87 0.005 
Period -.0947913 .1077513 -0.88 0.380 
BCS .1080006 .039687 2.72 0.007 
Sex -.1598771 .1077513 -1.48 0.140 
 
 
 
 
 
Appendix Table 5A. Regression table for plasma IGF-I. 
 
Source DF Partial SS Mean Square 
    
Model 4 68036.8558 17009.2319 
Residual 202 2359110.7 11678.7658 
    
Total 206 2427147.55 11782.2697 
 
Leptin Coef. Std. Error t P> [t] 
     
Day .421547 2.366767 0.18 0.859 
Period -17.97574 15.10427 -1.19 0.235 
BCS -.1487325 7.552216 -0.02 0.984 
Sex -32.51352 15.10443 -2.15 0.033 
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Appendix Table 6A. ANOVA table for plasma IGF-I. 
 
Source DF Partial SS Mean Square F Value Pr>F 
      
Model 13 120845.186 9295.78353 0.78 0.6829 
Day 10 53178.8212 5317.88212 0.45 0.9225 
Period 1 15987.1448 15987.1448 1.34 0.2488 
BCS 1 .395669018 .395669018 0.00 0.9954 
Sex 1 52807.5162 52807.5162 4.42 0.0368 
Residual 193 2306302.37 11949.7532   
      
Total 206 2427147.55 11782.2697   
 
 
 
 
 
Appendix Table 7A. Description of project horses.  
 
Horse Age Sex Breed Type 
    
Ed 21 Stallion Quarter Horse 
Special 14 Stallion Quarter Horse 
Peppy 6 Stallion Quarter Horse 
Menace 6 Stallion Thoroughbred 
Dundee 10 Stallion Quarter Horse 
    
Ben 10 Gelding Quarter Horse 
Jerry 14 Gelding Paint Horse 
Oliver 15 Gelding Thoroughbred 
Roman 10 Gelding Appaloosa 
Zippy 10 Gelding Quarter Horse 
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